5th Circuit Dupixent news shows skin cancer cases across Louisiana, Mississippi, and Texas. While the full extent of lymphoma unmasking continues to emerge, MDL compensation is now being sought for eczema and asthma medication victims.
To learn more, please see our information on claiming a 5th Circuit Dupixent settlement.
Louisiana Dupixent News
Louisiana Dupixent news reports indicate widespread development or unmasking of T-Cell lymphoma.
- LA Dupixent News – Coming Soon / As Available
If you were diagnosed with skin cancer following eczema or asthma treatment, contact us about filing a Louisiana Dupixent lawsuit.
Mississippi Dupixent News
Mississippi Dupixent news reports indicate widespread development or unmasking of T-Cell lymphoma.
- MS Dupixent News – Coming Soon / As Available
If you were diagnosed with skin cancer following eczema or asthma treatment, contact us about filing a Mississippi Dupixent lawsuit.
Texas Dupixent News
Texas Dupixent news reports indicate widespread development or unmasking of T-Cell lymphoma.
- TX Dupixent News – Coming Soon / As Available
If you were diagnosed with skin cancer following eczema or asthma treatment, contact us about filing a Texas Dupixent lawsuit.
5th Circuit Dupixent News Supports MDL Settlement for Skin Cancer
5th Circuit Dupixent news of T-cell lymphoma has raised concerns for eczema and asthma patients in Louisiana, Mississippi, and Texas. As such, public support is growing for the court’s certification of a Dupixent Multi-District Litigation (MDL) to administer claims.
Lymphoma Attorneys Act on 5th Circuit Dupixent News of Skin Cancer
Reporting skin cancer is an important first step to justice. If your family has been impacted by Dupixent, contact us about filing a 5th Circuit settlement claim.
For background information on T-cell lymphoma, please see our Dupixent lawyers homepage.